From revolutionary science to the impact of Obamacare, every week The Motley Fool's health care team sits down to discuss the most fascinating developments across the health care industry and their implications for long-term investors. In this week's edition, the team talks about the disruptive potential of a new iPhone app, as well as an FDA inquiry that could have negative implications for some of the pharmaceutical industry's biggest players. In addition, our analysts dive into some of the stocks making big moves over the past week and discuss companies on their radar for the near future.
In the following segment, health care bureau chief Brenton Flynn discusses a big customer loss for medical distributor Cardinal Health (NYSE:CAH) and why it doesn't worry him as much as another ongoing development -- industry consolidation.
The relevant video segment can be found between 10:55 and 12:42.